| Title: |
The Prognostic Value of Circulating Stem Cells Expressing PD-L1 in Patients with Hepatocellular Carcinoma. |
| Authors: |
Roy, Dhruvajyoti; Oppermann, Elsie; Vogl, Thomas J; Büdeyri, Ibrahim; Shapiro, Dmitry; Struecker, Benjamin; Rolfo, Christian D; Abedin, Nada; Zharov, Vladimir P; Schnitzbauer, Andreas; Pascher, Andreas; Bechstein, Wolf O; Zimmermann, Markus S; Juratli, Mazen A |
| Source: |
Journal of Hepatocellular Carcinoma; May2026, Vol. 13, p1-15, 15p |
| Subject Terms: |
Hepatocellular carcinoma; Programmed death-ligand 1; Immune checkpoint inhibitors; Mesenchymal stem cells; Prognosis; Progression-free survival; Overall survival; Biomarkers |
| Abstract: |
Background: Hepatocellular carcinoma (HCC) is associated with high recurrence rates despite curative-intent liver resection. This necessitates improved prognostic tools and novel therapeutic strategies, including immune checkpoint inhibitors (ICIs). Circulating stem cells (CSCs) have emerged as potential prognostic biomarkers. Aim: To assess the prognostic relevance of CSCs expressing programmed death-ligand 1 (PD-L1+CSCs) in relation to recurrence-free survival (RFS) and overall survival (OS) in patients undergoing surgery for HCC. Methods: PD-L1+CSCs (CD45−/CD146+/ASGPR+/CD90+/PD-L1+) were analyzed in 27 HCC patients before surgery, immediately after surgery, and at 6 and 12 months after surgery using fluorescence-activated cell sorting and immunofluorescence microscopy. Tumor recurrence was monitored biannually through alpha-fetoprotein (AFP) measurements and imaging (CT/MRI). Control groups included patients with benign liver disease, non-HCC malignancies, and healthy donors. Results: Before surgery, 29.7% (8/27) of HCC patients had detectable PD-L1+CSCs. Postoperatively, their frequency initially declined to 22.3%, followed by a significant rise to 85% at six months and 88% at twelve months (both p |
| : |
Copyright of Journal of Hepatocellular Carcinoma is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |